Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey

被引：0
|
作者：
Hiroki Murayama
Kota Imai
Masato Odawara
机构：
[1] Novartis Pharma K.K,Medical Division
[2] Tokyo Medical University,Department of Diabetes, Endocrinology, Metabolism, and Rheumatology
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Diabetes nonspecialist; Diabetes specialist; Drug-naive; Japan; First line; Metformin; Online survey; Oral antidiabetes drugs; Treatment choices; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1199
页数：14
相关论文
共 50 条
  • [1] Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey
    Murayama, Hiroki
    Imai, Kota
    Odawara, Masato
    DIABETES THERAPY, 2018, 9 (03) : 1185 - 1199
  • [2] Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians’ Perspective in a Real-World Setting, Insight from a Web Survey
    Kota Imai
    Hiroki Murayama
    Takahisa Hirose
    Diabetes Therapy, 2018, 9 : 1869 - 1881
  • [3] Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians' Perspective in a Real-World Setting, Insight from a Web Survey
    Imai, Kota
    Murayama, Hiroki
    Hirose, Takahisa
    DIABETES THERAPY, 2018, 9 (05) : 1869 - 1881
  • [4] Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database
    Morita, Yohei
    Murayama, Hiroki
    Odawara, Masato
    Bauer, Melissa
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (01)
  • [5] Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database
    Yohei Morita
    Hiroki Murayama
    Masato Odawara
    Melissa Bauer
    Diabetology & Metabolic Syndrome, 11
  • [6] Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus
    Guo, Lixin
    Xi, Yue
    Li, Li
    Guo, Kunquan
    Wu, Jun
    Xu, Jiawei
    Wang, Yihua
    Wu, Guangyu
    Si, Si
    DIABETES OBESITY & METABOLISM, 2024, 26 (07) : 2979 - 2983
  • [7] Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting
    Melzer-Cohen, Cheli
    Chodick, Gabriel
    Naftelberg, Shiran
    Shehadeh, Naim
    Karasik, Avraham
    DIABETES THERAPY, 2020, 11 (01) : 185 - 196
  • [8] Efficacy and safety of saxagliptin in drug-naive Asian patients with type 2 diabetes mellitus: a randomized controlled trial
    Pan, Chang Yu
    Yang, Wenying
    Tou, Conrad
    Gause-Nilsson, Ingrid
    Zhao, June
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 (03) : 268 - 275
  • [9] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
  • [10] Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
    Chen, Tse-Ying
    Hsieh, Ching-Jung
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 205 - 215
12345